ʻO ka lawe ʻana i ka lāʻau lapaʻau i manaʻo ʻia no ka maʻi maʻi maʻi: He Manaʻo Nui

Nūhou

 ʻO ka lawe ʻana i ka lāʻau lapaʻau i manaʻo ʻia no ka maʻi maʻi maʻi: He Manaʻo Nui 

2025-03-09

Hāʻawi ʻia ka lāʻau lapaʻau no ka maʻi kanesa e kālele ana i ka hāʻawi ʻana i nā lāʻau lapaʻau kūikawā i nā cell cancer, e hōʻemi ana i ka pōʻino i nā ʻiʻo olakino. Ke hoʻohana nei kēia ala i nā hoʻolālā like ʻole, me nā nanoparticles, antibodies, a me nā peptides cell-penetrating, e hoʻomaikaʻi i ka pono o ka lāʻau lapaʻau a hōʻemi i nā hopena ʻaoʻao, e hāʻawi ana i kahi lāʻau lapaʻau maʻi maʻi maʻi.

ka hoomaopopo ana Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi

Ua ulu nui ka mālama ʻana i ka maʻi maʻi, me ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa e puka mai ana ma ke ʻano he hoʻolālā hoʻohiki. Ke manaʻo nei kēia ala e hāʻawi i nā lāʻau lapaʻau i nā cell cancer, e hoʻonui i nā hopena therapeutic aʻo ka hōʻemi ʻana i ka pōʻino i nā ʻiʻo olakino. ʻAʻole like me ka chemotherapy maʻamau, ka mea e puʻunaue ana i nā lāʻau lapaʻau a puni ke kino, hoʻohana ʻia ka lawe ʻana i nā ʻano hana like ʻole e hoʻopaʻa pono ai i nā cell cancer.

No ke aha Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi Nā mea pili

ʻO ka chemotherapy maʻamau ka hopena i nā hopena koʻikoʻi no ka mea e pili ana i nā maʻi maʻi a me nā cell olakino. Hāʻawi ʻia ka lāʻau lapaʻau no ka maʻi kanesa hāʻawi i kahi hoʻonā ma ka hāʻawi ʻana i nā lāʻau lapaʻau i ka pūnaewele tumor. Hoʻemi kēia i ka ʻona ʻōnaehana, hoʻomaikaʻi i ka pono o ka lāʻau, a hiki ke hoʻonui i ka maikaʻi o ke ola o ka maʻi.

Nā papahana no Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi

Hoʻohana ʻia kekahi mau hoʻolālā hou i ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa, kēlā me kēia me kona pono pono'ī a me nā palena.

Nanoparticles

ʻO nā nanoparticles nā ʻāpana liʻiliʻi (1-100 nm) i hoʻolālā ʻia e hoʻopili a hāʻawi i nā lāʻau lapaʻau i nā maʻi kanesa. Hiki iā lākou ke hana ʻia e hoʻopaʻa i nā mea loaʻa kikoʻī ma nā pūnaewele maʻi kanesa, e like me EGFR a i ʻole HER2. Hoʻohana mau ʻia nā liposomes, nā nanoparticles polymeric, a me nā nanoparticles inorganic. ʻO ka hopena i hoʻonui ʻia i ka permeability a me ka hoʻopaʻa ʻana (EPR) hiki i nā nanoparticles ke hōʻiliʻili i nā ʻiʻo tumora ma muli o ka leaky vasculature.

Laʻana: ʻO Doxil, kahi liposomal doxorubicin, he lāʻau lapaʻau i hoʻohana ʻia no ka mālama ʻana i ka maʻi ovarian a me ka myeloma lehulehu.

ʻO nā mea hoʻohui lāʻau antibody (ADC)

Aia nā ADC i kahi antibody monoclonal i hoʻopili ʻia i kahi lāʻau cytotoxic. Hoʻopaʻa paʻa ka antibody i kahi antigen i hoʻopaʻa ʻia ma nā maʻi kanesa, e alakaʻi ana i ka internalization o ka ADC a me ka hoʻokuʻu ʻana o ka lāʻau i loko o ke kelepona.

Laʻana: Hoʻokumu ʻo Adcetris (brentuximab vedotin) i ka CD30, he pūmua i loaʻa ma kekahi mau pūnaewele lymphoma, e hāʻawi ana i kahi microtubule-disrupting agent.

Nā Peptides Kuʻi Paʻi Paʻa (CPP)

ʻO nā CPP nā ʻāpana amino acid pōkole e hoʻomaʻamaʻa i ke komo ʻana o nā lāʻau lapaʻau a i ʻole nā nanoparticles i loko o nā cell. Hiki iā lākou ke hoʻohui ʻia i nā mea therapeutic a i ʻole nanoparticles e hoʻomaikaʻi i kā lākou cellular uptake.

Endocytosis i hoʻopili ʻia e ka Receptor

Hoʻopili kēia hoʻolālā i ka huli ʻana i nā mea loaʻa i hoʻohālikelike ʻia i nā maʻi kanesa. Hoʻohana ʻia nā ligands a i ʻole nā ​​antibodies e hoʻopaʻa i kēia mau mea loaʻa e hoʻopuka i nā lāʻau lapaʻau a i ʻole nanoparticles ma o ka endocytosis.

ʻO Shandong Baofa Cancer Research Institute's Role

Ke komo ikaika nei ka Shandong Baofa Cancer Research Institute i ka noiʻi ʻana a me ka hoʻomohala ʻana i ka moʻolelo ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa ʻōnaehana. Ke nānā nei kā lākou noiʻi ʻana i nā ala pilikino e noʻonoʻo ana i nā ʻano genetic a me nā molecular profiles o kēlā me kēia maʻi, e manaʻo ana e hoʻomaikaʻi i nā hopena lapaʻau a hōʻemi i nā hopena ʻaoʻao.

Hana pū ʻo Shandong Baofa Cancer Research Institute me nā halemai e like me ka Shandong Baofa Cancer Hospital (https://baofahospital.com) e hana i nā hoʻokolohua lapaʻau a unuhi i nā ʻike noiʻi i loko o nā noi kūpono.

Pono o Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi

Hāʻawi ʻia ka lāʻau lapaʻau no ka maʻi kanesa Hāʻawi ia i kekahi mau mea pono nui ma mua o ka chemotherapy maʻamau:

  • Hoʻemi ʻia ka ʻawaʻawa: Ma ka huli pono ʻana i nā cell cancer, hoʻemi ʻia ka ʻike ʻana o nā ʻiʻo olakino i nā lāʻau ʻawaʻawa, e alakaʻi ana i ka liʻiliʻi o nā hopena ʻaoʻao.
  • Hoʻomaikaʻi maikaʻi ʻia: Hiki ke hāʻawi pololei ʻia ka ʻoi aku o ka nui o nā lāʻau lapaʻau i ka pae maʻi maʻi, hiki ke hoʻonui i ka hopena therapeutic.
  • Lapaʻau pilikino: Hāʻawi ʻia ka lāʻau lapaʻau no ka maʻi kanesa hiki ke hoʻohālikelike ʻia i nā ʻano kikoʻī o ka maʻi maʻi maʻi, e alakaʻi ana i nā hoʻolālā lapaʻau ʻoi aku ka maikaʻi a pilikino.
  • Ke lanakila 'ana i ka lā'au kū'ē: ʻO kekahi ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa hiki i nā ʻōnaehana ke lanakila i nā mīkini kūʻē i ka lāʻau lapaʻau, e ʻoi aku ka maʻalahi o nā cell cancer i ka mālama ʻana.

ʻO ka lawe ʻana i ka lāʻau lapaʻau i manaʻo ʻia no ka maʻi maʻi maʻi: He Manaʻo Nui

Nā pilikia ma Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi

ʻOiai kāna ʻōlelo hoʻohiki, ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa ke alo nei i kekahi mau pilikia:

  • Kūlana kikoʻī: He mea koʻikoʻi ka hōʻoia ʻana e hoʻopaʻa ʻia ka mea hoʻopaʻa ʻia i nā maʻi kanesa a ʻaʻole i nā ʻiʻo olakino.
  • ʻO ke komo ʻana o ka tumora: He mea paʻakikī ka hāʻawi ʻana i nā lāʻau lapaʻau i nā wahi āpau o ka ʻōpū, ʻoi aku ka paʻakikī me ka stroma paʻa.
  • Hoʻokuʻu lāʻau lapaʻau: ʻO ka hoʻomalu ʻana i ka hoʻokuʻu ʻana o ka lāʻau lapaʻau ma ka pūnaewele tumor ka mea nui e hoʻonui i kona hopena therapeutic.
  • Immunogenicity: ʻO kekahi ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa ʻO nā ʻōnaehana, e like me nā mea i hoʻokumu ʻia i nā antibodies a i ʻole nā ​​viruses, hiki ke kiʻi i kahi pane kūlohelohe, e kaupalena ana i ko lākou pono.
  • Uku: ʻO ka hoʻomohala ʻana a me ka hana ʻana o ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa hiki ke pipiʻi nā ʻōnaehana.

ʻO ka lawe ʻana i ka lāʻau lapaʻau i manaʻo ʻia no ka maʻi maʻi maʻi: He Manaʻo Nui

Nā laʻana o Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi i ka hoʻohana lāʻau lapaʻau

He mau ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa ʻae ʻia nā ʻōnaehana i kēia manawa no ka hoʻohana lāʻau lapaʻau:

Inoa Laau Laau Kuhikuhi ʻAno maʻi maʻi maʻi Kaʻina Hoʻouna
Doxil (liposomal doxorubicin) ʻO ka huli ʻana ma o ka hopena EPR ʻO ka maʻi maʻi ovarian, Multiple myeloma Liposome
Adcetris (brentuximab vedotin) CD30 Hodgkin lymphoma, Anaplastic nui cell lymphoma Hoʻohui lāʻau antibody (ADC)
Kadcyla (trastuzumab emtansine) HE2 ʻO ka maʻi maʻi umauma HER2 maikaʻi Hoʻohui lāʻau antibody (ADC)

Nā kuhikuhi e hiki mai ana ma Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi

Ke kahua o ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa ke ulu wikiwiki nei. E nānā ka noiʻi e hiki mai ana ma:

  • Ke hoʻomohala ʻana i nā mea kikoʻī kikoʻī a maikaʻi hoʻi.
  • Hoʻomaikaʻi i ke komo ʻana o ka tumora a me ka hoʻokuʻu lāʻau.
  • Hoʻohui ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa me nā lāʻau lapaʻau ʻē aʻe, e like me ka immunotherapy a me ka radiation therapy.
  • Ke hoʻomohala ʻana i ka pilikino ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa nā hoʻolālā e pili ana i nā hiʻohiʻona kūʻokoʻa o nā maʻi maʻi o kēlā me kēia maʻi.
  • Ke hoʻohana ʻana i ka naʻauao artificial e hoʻolālā a hoʻopono ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa ʻōnaehana.

Hāʻawi ʻia ka lāʻau lapaʻau no ka maʻi kanesa paʻa i ka ʻōlelo hoʻohiki nui no ka hoʻomaikaʻi ʻana i ka mālama ʻana i ka maʻi kanesa a me nā hopena maʻi. Ke hoʻomau nei ka noiʻi, hiki iā mākou ke manaʻo e ʻike ʻoi aku ka maikaʻi a pilikino ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa puka mai nā hoʻolālā, i ka hopena e alakaʻi i ka mālama maʻi maʻi ʻoi aku ka maikaʻi.

Home
Nā hihia maʻamau
No makou
Hoʻokaʻaʻike iā mākou

E ʻoluʻolu e waiho i kahi leka iā mākou